Related Experiment Videos
Skin graft rejection by beta 2-microglobulin-deficient mice
M Zijlstra1, H Auchincloss, J M Loring
1Whitehead Institute for Biomedical Research, Cambridge, Massachusetts.
The Journal of Experimental Medicine
|April 11, 1992
Summary
Mice lacking major histocompatibility complex class I (MHC-I) molecules reject some skin grafts normally but show reduced rejection of H-Y disparate grafts, indicating MHC-I’s role in specific immune responses.
Area of Science:
- Immunology
- Transplantation Biology
Background:
- Beta 2-microglobulin (beta 2-m) is crucial for functional major histocompatibility complex class I (MHC-I) molecules.
- Mice with a beta 2-m gene disruption lack MHC-I expression and MHC-I-directed CD8+ cytotoxic T lymphocytes (CTLs).
Purpose of the Study:
- To investigate the role of MHC-I-directed immunity in skin allograft rejection using beta 2-m mutant mice.
- To determine the necessity of CD8+ CTLs in rejecting grafts with significant or minor histocompatibility differences.
Main Methods:
- Utilized beta 2-microglobulin (beta 2-m) gene-disrupted mice lacking functional MHC-I.
- Assessed skin graft rejection in mutant mice across various histocompatibility barriers (MHC, minor H, H-Y).
- Compared the graft rejection capabilities of natural killer (NK) cells against MHC-I-deficient bone marrow and skin grafts.
Main Results:
- MHC-I-directed CD8+ CTLs are not essential for rejecting allografts with whole MHC or multiple minor H differences.
- Absence of MHC-I-guided immunity significantly impairs the rejection of H-Y disparate skin grafts.
- Natural killer (NK) cells effectively reject MHC-I-deficient bone marrow grafts but not MHC-I-deficient skin grafts.
Conclusions:
- MHC-I-directed immunity plays a critical, though not absolute, role in skin graft rejection, particularly for H-Y disparate grafts.
- The effectiveness of immune mechanisms, like NK cell activity, in graft rejection is context-dependent and influenced by graft type and MHC-I expression.